Form 4 Filing for BIODESIX INC

John Patience, Chairman and Director of BIODESIX INC, reported a transaction on September 30, 2026. He acquired 1360 shares of Common Stock and disposed of 1360 Restricted Stock Units (RSUs). The RSUs represent a contingent right to receive one share of Common Stock each and vest in four installments throughout 2026, subject to continued service. Following these transactions, Patience directly owns 26,743 shares of Common Stock. He also holds shares indirectly through Patience Enterprises LP (107,664 shares), John Patience Living Trust (241,480 shares), and his spouse (2,649 shares). The acquisition of common stock had a price per share of 0.0, and the disposed RSUs also had a price per share of 0.0.